Low IL-1alpha expression in bladder cancer tissue and survival.

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Interleukin-1 alpha (IL-1alpha) is implicated in cancer development and progression.
• Previous studies suggested a link between IL-1alpha mRNA levels and survival in urinary bladder cancer.
• The precise role and mechanism of IL-1alpha in bladder cancer require further elucidation.

Purpose of the Study:

• To validate the association between IL-1alpha mRNA levels and survival in a larger urinary bladder cancer patient cohort.
• To explore potential mechanisms underlying the observed antitumoral activity of IL-1alpha.

Main Methods:

• Quantitative TaqMan PCR was used to measure IL-1alpha mRNA levels in 164 urinary bladder cancer tumors.
• Immunohistochemistry was employed to determine the cellular localization of IL-1alpha expression.
• Univariate and bivariate Cox proportional hazards models were utilized to analyze survival data.

Main Results:

• IL-1alpha mRNA levels exhibited significant variation across tumors.
• IL-1alpha was predominantly expressed by tumor cells, not stromal cells.
• Univariate analysis indicated that low IL-1alpha mRNA levels were associated with an increased risk of cancer-specific death (RHR=1.7).
• This association lost statistical significance in bivariate analyses after adjusting for age, stage, and grade, suggesting potential confounding.

Conclusions:

• Low IL-1alpha mRNA expression in urinary bladder cancer is associated with a higher risk of cancer-specific mortality.
• Confounding factors significantly impact the observed association, necessitating further research.
• Establishing a causal relationship requires a defined mechanism and corroborating data from additional studies.